Literature DB >> 23408458

The role of SCARB2 as susceptibility factor in Parkinson's disease.

Franziska Hopfner1, Eva C Schulte, Brit Mollenhauer, Benjamin Bereznai, Franziska Knauf, Peter Lichtner, Alexander Zimprich, Dietrich Haubenberger, Walter Pirker, Thomas Brücke, Annette Peters, Christian Gieger, Gregor Kuhlenbäumer, Claudia Trenkwalder, Juliane Winkelmann.   

Abstract

BACKGROUND: Genetic variation in the glucocerebrosidase (GBA) gene is strongly associated with Parkinson's disease (PD). Transport of glucocerebrosidase to the lysosome involves the protein encoded by the SCARB2 gene. An association between the common SNP rs6812193, upstream of SCARB2, and PD has been reported previously. The role of exonic variants in the SCARB2 gene in PD has not been examined.
METHODS: We studied the role of exonic variants in SCARB2 and tried to replicate the association between the SNP rs6812193 and PD in a German and Austrian sample. Screening of all SCARB2 exons by high-resolution melting curve analysis was performed in 376 German PD patients. The SNP rs6812193 was analyzed in 984 PD patients and 1014 general population controls.
RESULTS: We identified no novel exonic variants in SCARB2 but confirmed the association between SNP rs6812193 and PD (OR, 0.86; P=.02).
Copyright © 2013 Movement Disorder Society.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23408458     DOI: 10.1002/mds.25349

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  17 in total

Review 1.  Lysosomal integral membrane protein-2: a new player in lysosome-related pathology.

Authors:  Ashley Gonzalez; Mark Valeiras; Ellen Sidransky; Nahid Tayebi
Journal:  Mol Genet Metab       Date:  2013-12-11       Impact factor: 4.797

2.  LIMP-2 expression is critical for β-glucocerebrosidase activity and α-synuclein clearance.

Authors:  Michelle Rothaug; Friederike Zunke; Joseph R Mazzulli; Michaela Schweizer; Hermann Altmeppen; Renate Lüllmann-Rauch; Wouter W Kallemeijn; Paulo Gaspar; Johannes M Aerts; Markus Glatzel; Paul Saftig; Dimitri Krainc; Michael Schwake; Judith Blanz
Journal:  Proc Natl Acad Sci U S A       Date:  2014-10-14       Impact factor: 11.205

3.  Association between rs6812193 polymorphism and sporadic Parkinson's disease susceptibility.

Authors:  Qiang Huo; Tao Li; Peiqing Zhao; Lianqing Wang
Journal:  Neurol Sci       Date:  2015-03-29       Impact factor: 3.307

Review 4.  Neuronal vulnerability in Parkinson disease: Should the focus be on axons and synaptic terminals?

Authors:  Yvette C Wong; Kelvin Luk; Kerry Purtell; Samuel Burke Nanni; A Jon Stoessl; Louis-Eric Trudeau; Zhenyu Yue; Dimitri Krainc; Wolfgang Oertel; Jose A Obeso; Laura A Volpicelli-Daley
Journal:  Mov Disord       Date:  2019-09-04       Impact factor: 10.338

Review 5.  Preserving Lysosomal Function in the Aging Brain: Insights from Neurodegeneration.

Authors:  Wesley Peng; Georgia Minakaki; Maria Nguyen; Dimitri Krainc
Journal:  Neurotherapeutics       Date:  2019-07       Impact factor: 7.620

Review 6.  [Genetics of tremor].

Authors:  G Kuhlenbäumer; F Hopfner
Journal:  Nervenarzt       Date:  2018-04       Impact factor: 1.214

Review 7.  Molecular mechanisms of α-synuclein and GBA1 in Parkinson's disease.

Authors:  Iva Stojkovska; Dimitri Krainc; Joseph R Mazzulli
Journal:  Cell Tissue Res       Date:  2017-10-24       Impact factor: 5.249

8.  No association of FAM47E rs6812193, SCARB2 rs6825004 and STX1B rs4889603 polymorphisms with Parkinson's disease in a Chinese Han population.

Authors:  YongPing Chen; XiaoQin Yuan; Bei Cao; QianQian Wei; RuWei Ou; Jing Yang; XuePing Chen; Bi Zhao; Wei Song; Ying Wu; HuiFang Shang
Journal:  J Neural Transm (Vienna)       Date:  2015-07-30       Impact factor: 3.575

Review 9.  Lysosomal trafficking defects link Parkinson's disease with Gaucher's disease.

Authors:  Yvette C Wong; Dimitri Krainc
Journal:  Mov Disord       Date:  2016-09-13       Impact factor: 10.338

Review 10.  Glucocerebrosidase is shaking up the synucleinopathies.

Authors:  Marina Siebert; Ellen Sidransky; Wendy Westbroek
Journal:  Brain       Date:  2014-02-14       Impact factor: 13.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.